NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EnChannel Medical

EnChannel Medical

Private
GuangzhouHealthcare & Life Scienceshttps://enchannel.com/

Last Round

Series B

May 1, 2025

Total Funding Raised

$110.2M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

EnChannel Medical is a surgical devices company that develops a cardiac electrophysiology platform for precise mapping and targeted treatment of complex heart rhythm disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

pulsed-field ablationPFAcardiac mappingatrial fibrillation treatmentelectrophysiologycardiac ablationnon-thermal ablationablation cathetermapping catheterAI cardiac mappingMedTechcardiac arrhythmiaAcQMap

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnChannel Medical Comparables

Compare EnChannel Medical with similar companies based on industry and business-model similarity.

EnChannel Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Argá Medtech
86%
Cortex, Inc.
81%
Pulsecare Medical
81%

EnChannel Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 1, 2025
Series AAug 1, 2023

Key People

Founding team and executive leadership

Jun Feng

CEO & Co-Founder

Founding Team

Min Zhu

Chief Technology Officer

Executive Team

EnChannel Medical Investors

Notable investors and investment history

EnChannel Medical investors
InvestorRounds
Lapam CapitalSeries B
Lilly Asia VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 25, 74% of headcount.

EnChannel Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EnChannel Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EnChannel Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Employee Range34
Year Founded2020
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.